Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections

Your RPS

Sunayana Shah appointed as chair of RPS’s Industrial Pharmacy Advisory Group

Sunayana Shah has been appointed chair of the Royal Pharmaceutical Society’s Industrial Pharmacy Advisory Group, which will advise on matters related to industrial pharmacy and pharmaceutical science.

Sunayana Shah

Source: Sunayana Shah

Sunayana Shah will be chair of the Society’s newly formed Industrial Pharmacy Advisory Group

Sunayana Shah, a Fellow of the Royal Pharmaceutical Society (RPS), has been appointed chair of the Society’s newly formed Industrial Pharmacy Advisory Group (IPAG), which replaces the Industrial Pharmacy Forum as of 2021.

IPAG will advise the Society’s national pharmacy boards on matters related to industrial pharmacy and pharmaceutical science. It will also support the RPS’s work in industry, including around the development, implementation and dissemination of professional standards.

Shah has experience of community pharmacy and the pharmaceutical industry. She has previously worked as head of regulatory and safety policy at the Association of the British Pharmaceutical Industry (ABPI), in which part of her role involved advising UK and EU government officials on international regulatory policy matters, including Brexit.

“As a consultative group, we hope to provide expert opinions and evidence-based leadership to inform RPS policy decisions and advice to government and other stakeholders,” Shah said, adding that she was looking forward to working closely with the RPS’s chief scientist, Gino Martini, and the RPS policy teams.

Martini offered his congratulations to Shah, adding that the Society is “delighted to have someone who brings a huge wealth of experience that can help the RPS.

“Having timely access to an empowered network of experts on the IPAG with varied backgrounds, from pharmaceutical scientists to pharmacists specialising in medical, regulatory, safety and manufacturing, is a real asset, and I look forward to working with her.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208547

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.